Advanced search
Publication Cover
Expert Opinion on Drug Metabolism & Toxicology Volume 11, 2015 - Issue 6
Submit an article Journal homepage
1,614
Views
13
CrossRef citations to date
0
Altmetric
Editorial

Strategies to overcome statin intolerance

Aris P AgouridisUniversity of Ioannina, Medical School, Department of Internal Medicine, 45110 Ioannina, Greece;Department of Clinical Biochemistry (Vascular Disease Prevention Clinics), Royal Free London Foundation Trust, Pond Street, London, UK
,
Devaki R NairDepartment of Clinical Biochemistry (Vascular Disease Prevention Clinics), Royal Free London Foundation Trust, Pond Street, London, UK
&
Dimitri P MikhailidisUniversity College London (UCL), University College London Medical School, Department of Clinical Biochemistry (Vascular Disease Prevention Clinics), Royal Free Hospital Campus Pond Street , London NW3 2QG, UK+2078302258; +2078302235; [email protected]
, MD FRCP FRCPath (Academic Head of Department)
Pages 851-855 | Published online: 18 Mar 2015

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Niki Katsiki, Dimitri P Mikhailidis & Maciej Banach. (2019) Lipid-lowering agents for concurrent cardiovascular and chronic kidney disease. Expert Opinion on Pharmacotherapy 20:16, pages 2007-2017.
Read now
Niki Katsiki, Genovefa Kolovou, Pablo Perez-Martinez & Dimitri P. Mikhailidis. (2018) Dyslipidaemia in the elderly: to treat or not to treat?. Expert Review of Clinical Pharmacology 11:3, pages 259-278.
Read now
Vana Kolovou, Helen Bilianou & Genovefa Kolovou. (2016) Safe use of statins: focus on muscle toxicity. Clinical Lipidology 11:1, pages 16-22.
Read now
Anastazia A. Kei, Theodosios D. Filippatos & Moses S. Elisaf. (2016) The safety of ezetimibe and simvastatin combination for the treatment of hypercholesterolemia. Expert Opinion on Drug Safety 15:4, pages 559-569.
Read now
Aris P Agouridis, Michael S Kostapanos & Moses S Elisaf. (2015) Statins and their increased risk of inducing diabetes. Expert Opinion on Drug Safety 14:12, pages 1835-1844.
Read now

Articles from other publishers (8)

Kosmas I. Paraskevas, Peter Gloviczki, Pier Luigi Antignani, Anthony J. Comerota, Alan Dardik, Alun H. Davies, Hans-Henning Eckstein, Gianluca Faggioli, Jose Fernandes e Fernandes, Gustav Fraedrich, George Geroulakos, Jonathan Golledge, Ajay Gupta, Victor S. Gurevich, Arkadiusz Jawien, Mateja K. Jezovnik, Stavros K. Kakkos, Michael Knoflach, Gaetano Lanza, Christos D. Liapis, Ian M. Loftus, Armando Mansilha, Andrew N. Nicolaides, Rodolfo Pini, Pavel Poredos, Robert M. Proczka, Jean-Baptiste Ricco, Tatjana Rundek, Luca Saba, Felix Schlachetzki, Mauro Silvestrini, Francesco Spinelli, Francesco Stilo, Jasjit S. Suri, Alexei V. Svetlikov, Clark J. Zeebregts, Seemant Chaturvedi, Frank J. Veith & Dimitri P. Mikhailidis. (2022) Benefits and drawbacks of statins and non-statin lipid lowering agents in carotid artery disease. Progress in Cardiovascular Diseases 73, pages 41-47.
Crossref
Louis Jacob, Roger-Axel Greiner, Mark Luedde & Karel Kostev. (2021) Prevalence of and Factors Associated With the Prescription of Fibrates Among Patients Receiving Lipid-Lowering Drugs in Germany. Journal of Cardiovascular Pharmacology 78:6, pages 885-890.
Crossref
E. V. Vinogradova, Z. I. Mikashinovich & E. S. Belousova. (2019) Effect of Statins (Zocor) on Oxygen-Dependent Processes in Muscle Tissue and Erythrocytes in Animals with Hypercholesterolemia. Acta Biomedica Scientifica (East Siberian Biomedical Journal) 4:3, pages 110-116.
Crossref
Alicia J. Jenkins, Emma Scott, Jordan Fulcher, Gary Kilov & Andrzej S. Januszewski. 2019. Comprehensive Cardiovascular Medicine in the Primary Care Setting. Comprehensive Cardiovascular Medicine in the Primary Care Setting 113 177 .
Niki Katsiki & Dimitri P Mikhailidis. (2018) Lipids: a personal view of the past decade. Hormones 17:4, pages 461-478.
Crossref
Sunghwan SuhChang Hee JungSoon-Jun HongJung-Sun KimSung Hee Choi. (2018) Statin Intolerance: an Overview of the Current Status and Possible Treatment Options. Journal of Lipid and Atherosclerosis 7:2, pages 77.
Crossref
Z. I. Mikashinovich & E. S. Belousova. (2016) Biochemical Changes in Erythrocytes as a Molecular Marker of Cell Damage during Long-Term Simvastatin Treatment. Bulletin of Experimental Biology and Medicine 161:4, pages 600-603.
Crossref
Kosmas I. Paraskevas, Dimitri P. Mikhailidis, Frank J. Veith & J. David Spence. (2015) Definition of Best Medical Treatment in Asymptomatic and Symptomatic Carotid Artery Stenosis. Angiology 67:5, pages 411-419.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.